Dishman Pharmaceutical & Chemicals Ltd has chalked out a Rs
500 crores for investing in its upcoming
pharmaceutical and chemical SEZ, spread over 390 acre near Bavla in Gujarat. It is in the process
of setting up Asia's largest facility to manufacture cancer drugs and other
high potency drugs at its Bavla facility.
The company has completed acquisition of land for its
pharmaceutical and chemical SEZ and is in the process of completing land
acquisition for its Engineering SEZ as well. The company will apply for the notification of both the SEZ’s
in next 15 to 30 days.
Dishman is expects to begin work on both the SEZ by last quarter
of 2008. This facility is designed and being commissioned by its subsidiary
Carbogen Amics AG (CA), who has expertise in this area. The company has shelled
out around Rs 50 crores for the construction work of this facility.
Source : Business Standard
|